BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, June 15, 2026
Home » Authors » Omar Ford

Omar Ford

Articles

ARTICLES

BSX CEO touts pipeline, future growth opportunities

Jan. 13, 2011
By Omar Ford

CEO discusses success, emerging overseas market

Jan. 11, 2011
By Omar Ford

Deals roundup: Hologic reports acquisition of Interlace for $125 million

Jan. 10, 2011
By Omar Ford
Hologic (Bedford, Massachusetts) is wasting little time this year expanding its product offerings through acquisitions. Just barely a week into 2011 and the firm is reporting that it has acquired Interlace Medical (Framingham, Massachusetts) – a privately held company, that develops the hysteroscopic tissue removal system MyoSure. (Medical Device Daily)
Read More

Financings roundup: Echo Therapeutics brings in nearly $5 million in funding

Jan. 7, 2011
By Omar Ford

Study: patients who don't meet criteria for ICD at greater risk

Jan. 6, 2011
By Omar Ford
According to a study published in the Jan. 5 issue of the Journal of the American Medical Association (JAMA) some patients who don't meet the criteria for implantable cardioverter-defibrillators (ICDs) have the devices implanted anyway, and could be at serious risk. (Medical Device Daily)
Read More

Veridex, MGH in partnership to develop next gen CTC test

Jan. 4, 2011
By Omar Ford
A new collaboration between Massachusetts General Hospital (MGH; Boston) and Veridex (Raritan, New Jersey), a Johnson & Johnson (J&J; New Brunswick, New Jersey) company, has been initiated to develop a circulating tumor cell (CTC) technology for capturing, counting and characterizing tumor cells found in patients' blood. (Medical Device Daily)
Read More

Cook's STABLE results could pave way for FDA approval

Dec. 27, 2010
By Omar Ford
Cook Medical (Bloomington, Indiana) could be making tremendous headway in obtaining FDA approval for its Zenith Dissection endovascular system, which is designed for the treatment of Type B aortic dissection. The med-tech company reported positive data from the STABLE clinical trial evaluating the application, which is comprised of a proximal endograft and a distal uncovered stent. (Medical Device Daily)
Read More

Lap-Band changes game or gastric bypass market

Dec. 23, 2010
By Omar Ford

Arthrosurface develops HemiCAP BIO implant

Dec. 21, 2010
By Omar Ford
It doesn't make sense to tear up an entire road when there's one patch of it that's damaged, nor does it make sense to replace a whole knee when the joint can be salvaged with one implant. That's the logic behind Arthrosurface's (Franklin, Tennessee) HemiCap platform technology, which is now aimed at providing a more biological solution for joint preservation. (Medical Device Daily)
Read More

Researchers find 'arm' could restore movement in patients

Dec. 20, 2010
By Omar Ford
Paralyzed patients being able to move objects with the power of their mind might not be such a foreign concept for much longer. A new study from the University of Chicago found that the performance of a brain-machine interface application designed to help paralyzed subjects move objects with their thoughts is improved with the addition of a robotic arm providing sensory feedback. (Medical Device Daily)
Read More
View All Articles by Omar Ford

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 12, 2026.
  • Neck exam

    Ethyreal launches to treat the underlying cause of Graves’, TED

    BioWorld
    Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
  • Illustration of Lactobacillus

    Microbiota modulates the antidepressant effects of GLP-1 analogues

    BioWorld Science
    Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
  • Genome sequence map

    EHA 2026: With new lenses, a changing view on pediatric cancers

    BioWorld
    In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
  • Microscopic image of chronic myeloid leukemia

    Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid

    BioWorld
    Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing